Over the years we have seen significant updates to regulations and guidance across the medical devices, in vitro diagnostic and pharmaceutical sectors. It is clearly well recognised that through the ...

Oxford Drug Design has been awarded a share of a £3 million Collaborative Discovery Programme (CDP) by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate. This initiative, funded by the ...

Cancer Grand Challenges, a pioneering initiative co-founded by Cancer Research UK and the US National Cancer Institute (NCI), has launched a global search to identify the most pressing challenges in ...

International trial marks leap forward in chemotherapy-induced neuropathy care In a landmark announcement from Paris, AlgoTherapeutix (AlgoTx) has heralded the successful completion of its ...

Pharma’s experience in honing the management of regulated product data and content presents some useful lessons for medical device suppliers as their own regulatory workloads increase. A steady ...

Conversations around AI can often either seem very futuristic, or centre around whether tools such as ChatGPT can be trusted to write an email to your boss. What is less acknowledged is the way in ...

4basebio has announced Dr Amy Walker as Chief Operating Officer 4basebio has announced the appointment of Dr Amy Walker as Chief Operating Officer of the company. Amy joined 4basebio in November 2020 ...

Research suggests that LLMs could be used to support trainee doctors, nurses and GPs The chatbot ChatGPT performed better than trainee doctors in assessing complex cases of respiratory disease in ...

AMLo Biosciences has announced the successful receipt of the UKCA mark for AMBLor, a groundbreaking histopathological biomarker test for identifying early-stage melanomas at low risk of progression.

Eli Lilly and Company has announced promising results from two phase 3 clinical trials, QWINT-1 and QWINT-3, evaluating the efficacy of once-weekly insulin efsitora alfa (efsitora) in adults with type ...

Promising results for novel orexin agonist in sleep-deprived volunteers Nxera Pharma, formerly known as Sosei Group, has announced that its partner, Centessa Pharmaceuticals, has reported encouraging ...